Sanofi (SNY) Payables (2016 - 2025)
Historic Payables for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $8.6 billion.
- Sanofi's Payables rose 620.08% to $8.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $8.6 billion, marking a year-over-year increase of 620.08%. This contributed to the annual value of $8.3 billion for FY2025, which is 178.58% up from last year.
- Sanofi's Payables amounted to $8.6 billion in Q4 2025, which was up 620.08% from $8.0 billion recorded in Q2 2025.
- In the past 5 years, Sanofi's Payables registered a high of $8.6 billion during Q4 2025, and its lowest value of $6.5 billion during Q2 2021.
- In the last 5 years, Sanofi's Payables had a median value of $7.9 billion in 2023 and averaged $7.6 billion.
- Its Payables has fluctuated over the past 5 years, first surged by 1942.31% in 2021, then crashed by 168.04% in 2022.
- Quarter analysis of 5 years shows Sanofi's Payables stood at $7.1 billion in 2021, then decreased by 1.68% to $7.0 billion in 2022, then increased by 13.43% to $7.9 billion in 2023, then rose by 2.34% to $8.1 billion in 2024, then increased by 6.2% to $8.6 billion in 2025.
- Its last three reported values are $8.6 billion in Q4 2025, $8.0 billion for Q2 2025, and $8.1 billion during Q4 2024.